美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=OCTREOTIDE ACETATE (PRESERVATIVE FREE)
符合检索条件的记录共12
2 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号076313产品号001
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.05MG BASE/ML
治疗等效代码AP参比药物
批准日期2005/03/28申请机构WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD
2药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号076313产品号002
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.5MG BASE/ML
治疗等效代码AP参比药物
批准日期2005/03/28申请机构WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD
3药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号076313产品号003
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.1MG BASE/ML
治疗等效代码AP参比药物
批准日期2005/03/28申请机构WEST-WARD PHARMACEUTICALS INTERNATIONAL LTD
4药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号077457产品号001
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.05MG BASE/ML
治疗等效代码AP参比药物
批准日期2006/02/10申请机构FRESENIUS KABI USA LLC
5药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号077457产品号002
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.1MG BASE/ML
治疗等效代码AP参比药物
批准日期2006/02/10申请机构FRESENIUS KABI USA LLC
6药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号077457产品号003
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.5MG BASE/ML
治疗等效代码AP参比药物
批准日期2006/02/10申请机构FRESENIUS KABI USA LLC
7药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号079198产品号001
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.05MG BASE/ML
治疗等效代码AP参比药物
批准日期2011/02/10申请机构MYLAN INSTITUTIONAL LLC
8药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号079198产品号002
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.1MG BASE/ML
治疗等效代码AP参比药物
批准日期2011/02/10申请机构MYLAN INSTITUTIONAL LLC
9药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号079198产品号003
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.5MG BASE/ML
治疗等效代码AP参比药物
批准日期2011/02/10申请机构MYLAN INSTITUTIONAL LLC
10药品名称OCTREOTIDE ACETATE (PRESERVATIVE FREE)
申请号090834产品号001
活性成分OCTREOTIDE ACETATE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 0.05MG BASE/ML
治疗等效代码AP参比药物
批准日期2013/11/12申请机构SAGENT PHARMACEUTICALS INC